James Passin, Chief Executive Officer, Ten Percent Owner at BioVaxys Technology, holds 3.56M shares in BioVaxys Technology (Ticker: BVAXF), holds 0.00 shares in St-Georges Platinum and Base Metals (Ticker: TSE:SX), holds 3.05M shares in Mindset Pharma Inc. (Ticker: TSE:MSET). Most recently, James Passin Bought ― shares of BioVaxys Technology on Nov 21, 2025 for an estimated value of $252.38K.
James Passin latest transaction was an Informative Buy of $252.38K.
What was James Passin's most profitable transaction?
James Passin’s most profitable transaction was an Informative Buy of SHIFF stock on June 26, 2019. The return on the trade was 255.40%.
What is James Passin's role in BioVaxys Technology?
James Passin's role in BioVaxys Technology is Chief Executive Officer, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.